Researchers at Kumamoto University have developed a highly sensitive blood test that can detect subtle differences in how ...
Researchers at Kumamoto University have developed a highly sensitive blood test that can detect subtle differences in how ...
Currently in phase 2 trials, BB-031 is the first new mechanistic approach to ischemic stroke treatment in nearly 30 years.
On November 2, 2025, the research group led by Dr. Zeng Ling from Army Medical University systematically elucidated the molecular mechanisms, ...
News Medical on MSN
HonorHealth patient first in Arizona to receive new investigational treatment for ischemic stroke
A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that ...
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and ...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today highlighted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback